 | • レポートコード：MRC2012A4100 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、胃腸治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃腸治療薬の種類別市場規模（処方胃腸薬、OTC胃腸薬）、用途別市場規模（慢性胃炎、機能性消化不良、消化性潰瘍、急性胃腸炎、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、Perrigo、Pfizer、Sanofi、Zeria（Tillotts）、Bayer、Purdue Pharma、Teva、GlaxoSmithKline、Boehringer Ingelheim、C.B. Fleet、Xian-Janssen、Abbott、Jiangzhong、 ・地域別グローバル市場分析 2015年-2020年 ・胃腸治療薬の北米市場（アメリカ、カナダ、メキシコ） ・胃腸治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・胃腸治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・胃腸治療薬の南米市場（ブラジル、アルゼンチン） ・胃腸治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：処方胃腸薬、OTC胃腸薬 ・用途別分析：慢性胃炎、機能性消化不良、消化性潰瘍、急性胃腸炎、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Gastrointestinal Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.8% in the forecast period of 2020 to 2025 and will expected to reach USD 36210 million by 2025, from USD 35130 million in 2019.
The Gastrointestinal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gastrointestinal Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gastrointestinal Drugs market has been segmented into
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
By Application, Gastrointestinal Drugs has been segmented into:
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastrointestinal Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastrointestinal Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastrointestinal Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Gastrointestinal Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gastrointestinal Drugs Market Share Analysis
Gastrointestinal Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastrointestinal Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastrointestinal Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Gastrointestinal Drugs are:
AstraZeneca
Perrigo
Pfizer
Sanofi
Zeria（Tillotts）
Bayer
Purdue Pharma
Teva
GlaxoSmithKline
Boehringer Ingelheim
C.B. Fleet
Xian-Janssen
Abbott
Jiangzhong
Among other players domestic and global, Gastrointestinal Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastrointestinal Drugs, with price, sales, revenue and global market share of Gastrointestinal Drugs in 2018 and 2019.
Chapter 3, the Gastrointestinal Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gastrointestinal Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gastrointestinal Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Gastrointestinal Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastrointestinal Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastrointestinal Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Overview of Global Gastrointestinal Drugs Market
1.4.1 Global Gastrointestinal Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Perrigo
2.2.1 Perrigo Details
2.2.2 Perrigo Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Perrigo SWOT Analysis
2.2.4 Perrigo Product and Services
2.2.5 Perrigo Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Zeria（Tillotts）
2.5.1 Zeria（Tillotts） Details
2.5.2 Zeria（Tillotts） Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Zeria（Tillotts） SWOT Analysis
2.5.4 Zeria（Tillotts） Product and Services
2.5.5 Zeria（Tillotts） Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer SWOT Analysis
2.6.4 Bayer Product and Services
2.6.5 Bayer Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Purdue Pharma
2.7.1 Purdue Pharma Details
2.7.2 Purdue Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Purdue Pharma SWOT Analysis
2.7.4 Purdue Pharma Product and Services
2.7.5 Purdue Pharma Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva
2.8.1 Teva Details
2.8.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teva SWOT Analysis
2.8.4 Teva Product and Services
2.8.5 Teva Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline SWOT Analysis
2.9.4 GlaxoSmithKline Product and Services
2.9.5 GlaxoSmithKline Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Boehringer Ingelheim
2.10.1 Boehringer Ingelheim Details
2.10.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Boehringer Ingelheim SWOT Analysis
2.10.4 Boehringer Ingelheim Product and Services
2.10.5 Boehringer Ingelheim Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 C.B. Fleet
2.11.1 C.B. Fleet Details
2.11.2 C.B. Fleet Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 C.B. Fleet SWOT Analysis
2.11.4 C.B. Fleet Product and Services
2.11.5 C.B. Fleet Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Xian-Janssen
2.12.1 Xian-Janssen Details
2.12.2 Xian-Janssen Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Xian-Janssen SWOT Analysis
2.12.4 Xian-Janssen Product and Services
2.12.5 Xian-Janssen Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Abbott
2.13.1 Abbott Details
2.13.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Abbott SWOT Analysis
2.13.4 Abbott Product and Services
2.13.5 Abbott Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Jiangzhong
2.14.1 Jiangzhong Details
2.14.2 Jiangzhong Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Jiangzhong SWOT Analysis
2.14.4 Jiangzhong Product and Services
2.14.5 Jiangzhong Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gastrointestinal Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gastrointestinal Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastrointestinal Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Gastrointestinal Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gastrointestinal Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Gastrointestinal Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gastrointestinal Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
4.5 South America Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gastrointestinal Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Gastrointestinal Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Gastrointestinal Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gastrointestinal Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Gastrointestinal Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gastrointestinal Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
6.3 UK Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
6.4 France Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gastrointestinal Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gastrointestinal Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gastrointestinal Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
7.5 India Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gastrointestinal Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Gastrointestinal Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Gastrointestinal Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gastrointestinal Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gastrointestinal Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gastrointestinal Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gastrointestinal Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Gastrointestinal Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Gastrointestinal Drugs Price by Type (2015-2020)
11 Global Gastrointestinal Drugs Market Segment by Application
11.1 Global Gastrointestinal Drugs Sales Market Share by Application (2015-2020)
11.2 Global Gastrointestinal Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Gastrointestinal Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gastrointestinal Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Gastrointestinal Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Gastrointestinal Drugs Market Forecast (2021-2025)
12.2.2 Europe Gastrointestinal Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gastrointestinal Drugs Market Forecast (2021-2025)
12.2.4 South America Gastrointestinal Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gastrointestinal Drugs Market Forecast (2021-2025)
12.3 Gastrointestinal Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Gastrointestinal Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Gastrointestinal Drugs Market Share Forecast by Type (2021-2025)
12.4 Gastrointestinal Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Gastrointestinal Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Gastrointestinal Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gastrointestinal Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gastrointestinal Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastrointestinal Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Gastrointestinal Drugs Major Business
Table 9. AstraZeneca Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 10. AstraZeneca SWOT Analysis
Table 11. AstraZeneca Gastrointestinal Drugs Product and Services
Table 12. AstraZeneca Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Perrigo Basic Information, Manufacturing Base and Competitors
Table 14. Perrigo Gastrointestinal Drugs Major Business
Table 15. Perrigo Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Perrigo SWOT Analysis
Table 17. Perrigo Gastrointestinal Drugs Product and Services
Table 18. Perrigo Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Gastrointestinal Drugs Major Business
Table 21. Pfizer Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer Gastrointestinal Drugs Product and Services
Table 24. Pfizer Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sanofi Basic Information, Manufacturing Base and Competitors
Table 26. Sanofi Gastrointestinal Drugs Major Business
Table 27. Sanofi Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Sanofi SWOT Analysis
Table 29. Sanofi Gastrointestinal Drugs Product and Services
Table 30. Sanofi Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Zeria（Tillotts） Basic Information, Manufacturing Base and Competitors
Table 32. Zeria（Tillotts） Gastrointestinal Drugs Major Business
Table 33. Zeria（Tillotts） Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Zeria（Tillotts） SWOT Analysis
Table 35. Zeria（Tillotts） Gastrointestinal Drugs Product and Services
Table 36. Zeria（Tillotts） Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bayer Basic Information, Manufacturing Base and Competitors
Table 38. Bayer Gastrointestinal Drugs Major Business
Table 39. Bayer Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Bayer SWOT Analysis
Table 41. Bayer Gastrointestinal Drugs Product and Services
Table 42. Bayer Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Purdue Pharma Gastrointestinal Drugs Major Business
Table 45. Purdue Pharma Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Purdue Pharma SWOT Analysis
Table 47. Purdue Pharma Gastrointestinal Drugs Product and Services
Table 48. Purdue Pharma Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Teva Basic Information, Manufacturing Base and Competitors
Table 50. Teva Gastrointestinal Drugs Major Business
Table 51. Teva Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Teva SWOT Analysis
Table 53. Teva Gastrointestinal Drugs Product and Services
Table 54. Teva Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 56. GlaxoSmithKline Gastrointestinal Drugs Major Business
Table 57. GlaxoSmithKline Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 58. GlaxoSmithKline SWOT Analysis
Table 59. GlaxoSmithKline Gastrointestinal Drugs Product and Services
Table 60. GlaxoSmithKline Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 62. Boehringer Ingelheim Gastrointestinal Drugs Major Business
Table 63. Boehringer Ingelheim Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Boehringer Ingelheim SWOT Analysis
Table 65. Boehringer Ingelheim Gastrointestinal Drugs Product and Services
Table 66. Boehringer Ingelheim Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. C.B. Fleet Basic Information, Manufacturing Base and Competitors
Table 68. C.B. Fleet Gastrointestinal Drugs Major Business
Table 69. C.B. Fleet Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 70. C.B. Fleet SWOT Analysis
Table 71. C.B. Fleet Gastrointestinal Drugs Product and Services
Table 72. C.B. Fleet Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Xian-Janssen Basic Information, Manufacturing Base and Competitors
Table 74. Xian-Janssen Gastrointestinal Drugs Major Business
Table 75. Xian-Janssen Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Xian-Janssen SWOT Analysis
Table 77. Xian-Janssen Gastrointestinal Drugs Product and Services
Table 78. Xian-Janssen Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Abbott Basic Information, Manufacturing Base and Competitors
Table 80. Abbott Gastrointestinal Drugs Major Business
Table 81. Abbott Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Abbott SWOT Analysis
Table 83. Abbott Gastrointestinal Drugs Product and Services
Table 84. Abbott Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Jiangzhong Basic Information, Manufacturing Base and Competitors
Table 86. Jiangzhong Gastrointestinal Drugs Major Business
Table 87. Jiangzhong Gastrointestinal Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Jiangzhong SWOT Analysis
Table 89. Jiangzhong Gastrointestinal Drugs Product and Services
Table 90. Jiangzhong Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Global Gastrointestinal Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 92. Global Gastrointestinal Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 93. Global Gastrointestinal Drugs Sales by Regions (2015-2020) (K Units)
Table 94. Global Gastrointestinal Drugs Sales Market Share by Regions (2015-2020)
Table 95. Global Gastrointestinal Drugs Revenue by Regions (2015-2020) (USD Million)
Table 96. North America Gastrointestinal Drugs Sales by Countries (2015-2020) (K Units)
Table 97. North America Gastrointestinal Drugs Sales Market Share by Countries (2015-2020)
Table 98. North America Gastrointestinal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 99. North America Gastrointestinal Drugs Revenue Market Share by Countries (2015-2020)
Table 100. Europe Gastrointestinal Drugs Sales by Countries (2015-2020) (K Units)
Table 101. Europe Gastrointestinal Drugs Sales Market Share by Countries (2015-2020)
Table 102. Europe Gastrointestinal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 103. Asia-Pacific Gastrointestinal Drugs Sales by Regions (2015-2020) (K Units)
Table 104. Asia-Pacific Gastrointestinal Drugs Sales Market Share by Regions (2015-2020)
Table 105. Asia-Pacific Gastrointestinal Drugs Revenue by Regions (2015-2020) (USD Million)
Table 106. South America Gastrointestinal Drugs Sales by Countries (2015-2020) (K Units)
Table 107. South America Gastrointestinal Drugs Sales Market Share by Countries (2015-2020)
Table 108. South America Gastrointestinal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 109. South America Gastrointestinal Drugs Revenue Market Share by Countries (2015-2020)
Table 110. Middle East & Africa Gastrointestinal Drugs Sales by Countries (2015-2020) (K Units)
Table 111. Middle East & Africa Gastrointestinal Drugs Sales Market Share by Countries (2015-2020)
Table 112. Middle East & Africa Gastrointestinal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 113. Middle East & Africa Gastrointestinal Drugs Revenue Market Share by Countries (2015-2020)
Table 114. Global Gastrointestinal Drugs Sales by Type (2015-2020) (K Units)
Table 115. Global Gastrointestinal Drugs Sales Share by Type (2015-2020)
Table 116. Global Gastrointestinal Drugs Revenue by Type (2015-2020) (USD Million)
Table 117. Global Gastrointestinal Drugs Revenue Share by Type (2015-2020)
Table 118. Global Gastrointestinal Drugs Sales by Application (2015-2020) (K Units)
Table 119. Global Gastrointestinal Drugs Sales Share by Application (2015-2020)
Table 120. Global Gastrointestinal Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 121. Global Gastrointestinal Drugs Market Share Forecast by Regions (2021-2025)
Table 122. Global Gastrointestinal Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 123. Global Gastrointestinal Drugs Market Share Forecast by Type (2021-2025)
Table 124. Global Gastrointestinal Drugs Sales Forecast by Application (2021-2025)
Table 125. Global Gastrointestinal Drugs Market Share Forecast by Application (2021-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gastrointestinal Drugs Picture
Figure 2. Global Sales Market Share of Gastrointestinal Drugs by Type in 2019
Figure 3. Prescription Gastrointestinal Drug Picture
Figure 4. OTC Gastrointestinal Drug Picture
Figure 5. Gastrointestinal Drugs Sales Market Share by Application in 2018
Figure 6. Chronic Gastritis Picture
Figure 7. Functional Dyspepsia Picture
Figure 8. Peptic Ulcer Picture
Figure 9. Acute Gastroenteritis Picture
Figure 10. Other Picture
Figure 11. Global Gastrointestinal Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Gastrointestinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Gastrointestinal Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Gastrointestinal Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Gastrointestinal Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Gastrointestinal Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Gastrointestinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Gastrointestinal Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Gastrointestinal Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Gastrointestinal Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Gastrointestinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Gastrointestinal Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Gastrointestinal Drugs Sales Market Share by Countries in 2018
Figure 48. North America Gastrointestinal Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Gastrointestinal Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Gastrointestinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Gastrointestinal Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Gastrointestinal Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Gastrointestinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Gastrointestinal Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Gastrointestinal Drugs Revenue Market Share by Regions 2019
Figure 64. China Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Gastrointestinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Gastrointestinal Drugs Sales Market Share by Countries in 2019
Figure 71. South America Gastrointestinal Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Gastrointestinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Gastrointestinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Gastrointestinal Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Gastrointestinal Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Gastrointestinal Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Gastrointestinal Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Gastrointestinal Drugs Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Gastrointestinal Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Gastrointestinal Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
胃腸OTC治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Gastrointestinal OTC Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gastrointestinal O…- 胃腸OTC薬の世界市場（～2026年） Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC…
- 胃腸装置の世界市場（～2026年） Market Analysis and Insights: Global Gastrointestinal Devices Market The global Gastrointestinal Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastrointestinal Devices Scope and Market Size Gastrointestinal D…
- 消化管間質腫瘍（GIST）の世界市場（～2026年） Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as path…
- ペプチド胃腸障害治療薬の世界市場（～2026年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…